Patient Recruitment Applications & Studies

  1. Recruitment At Warp Speed: Supporting A Moderna COVID-19 Vaccine Study 10/21/2021

    In this presentation, Diane Montross of Moderna discusses recruitment challenges, including the need for speed and diversity of participants. She’s joined by Mike Wenger of Informa Pharma Intelligence, who shares how Citeline Connect helped Moderna overcome those challenges.

  2. Phase I Study With Hypogonadal Males 10/12/2021

    Delve into a study that required the fast recruitment of a large group of study subjects, split into multiple cohorts, all of whom had very low testosterone. In this case study, find out how quickly subjects were recruited, which led to exceeding client expectations.

     

  3. Clinical Trial Recovery - Rescue Site 10/12/2021

    A large pharma Sponsor approached QPS to complete recruitment and enrollment of a very small and challenging trial evaluating hepatic function. This case study outlines the challenges faced and the solutions put in place to deliver the study successfully.

  4. Clinical Trial Study Subject Retention 10/12/2021

    A biotech company approached QPS to conduct a trial with healthy volunteers, where those volunteers were required to have a specific level of IgG and needed to remain in the study for a period of 1 year. This case study outlines the challenges faced and the solutions put into place to deliver the study successfully.

  5. Clinical Trial Recovery - Rescued Cohorts 10/12/2021

    A large pharma Sponsor approached QPS to jump into a trial early and complete initial phases of recruitment and enrollment into a large, multi-cohort clinical trial. This case study outlines the challenges faced and the solutions put in place to deliver the study successfully.

  6. Datavant Life Sciences Case Study: Finding Rare Disease Patients 9/23/2021

    Hereditary ATTR amyloidosis is a rare disease that affects 50,000 patients world-wide, shortening patient life expectancy to between five and thirteen years.1 Read how Datavant tracked down these patients.

  7. Leading Sponsor Delivers Enrollment 24 Months Ahead Of Schedule 9/20/2021

    Read the available case study to see how a leading sponsor delivers enrollment twenty four months ahead of schedule.

  8. Overcoming Trial Recruitment Challenges In NASH Using De-Identified Patient Linking 8/25/2021

    Recruiting patients for non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) trials can be a challenge. Read on to see how this challenge was overcome.

  9. Study Start-Up And Enrollment 7/27/2021

    IQVIA Biotech was approached by a clinical-stage biopharmaceutical company to run its Phase II prostate cancer drug trial in the U.S. For more information, download the available case study.

  10. Achieving Recruitment Objectives In Dermatology Trial: Reducing Timeline And Cost 7/26/2021

    IQVIA Biotech was selected to help a U.S. biopharmaceutical company examine the safety and efficacy of its investigational therapy for the treatment of moderate-to-severe hidradenitis suppurativa (HS), a chronic skin condition that causes small, but painful lumps under the skin. This case study will highlight IQVIA Biotech’s unique strategies for site selection and centralized recruitment approach to drive enrollment.